you are here: Home News Bafna Pharmaceuticals

Bafna Pharmaceuticals

Bafna Pharma Standalone September 2025 Net Sales at Rs 35.47 crore, down 12.04% Y-o-Y
Bafna Pharma Standalone March 2025 Net Sales at Rs 39.06 crore, down 5.65% Y-o-Y
Bafna Pharma Standalone December 2024 Net Sales at Rs 33.19 crore, up 16.68% Y-o-Y
Bafna Pharma Standalone September 2024 Net Sales at Rs 40.32 crore, down 0.87% Y-o-Y
Bafna Pharma Standalone June 2024 Net Sales at Rs 33.29 crore, down 20.65% Y-o-Y
Bafna Pharma Standalone March 2024 Net Sales at Rs 41.40 crore, down 2% Y-o-Y
Bafna Pharma Standalone December 2023 Net Sales at Rs 28.44 crore, down 16.88% Y-o-Y
Bafna Pharma Standalone September 2023 Net Sales at Rs 40.68 crore, up 85.23% Y-o-Y
Bafna Pharma Standalone June 2023 Net Sales at Rs 41.95 crore, up 147.81% Y-o-Y
Bafna Pharma Standalone March 2023 Net Sales at Rs 42.24 crore, up 181.96% Y-o-Y
Bafna Pharma Standalone December 2022 Net Sales at Rs 34.22 crore, up 67.25% Y-o-Y
Bafna Pharma Standalone June 2022 Net Sales at Rs 16.93 crore, down 20.38% Y-o-Y
Bafna Pharma Standalone March 2022 Net Sales at Rs 14.98 crore, down 31.4% Y-o-Y
Bafna Pharma Standalone December 2021 Net Sales at Rs 20.46 crore, up 17.08% Y-o-Y
In talks with multinational pharma cos for acquisition of brands: Bafna Pharmaceuticals
Bafna Pharma Standalone June 2021 Net Sales at Rs 21.26 crore, up 27.28% Y-o-Y
Bafna Pharma Standalone December 2020 Net Sales at Rs 17.48 crore, up 59.95% Y-o-Y
Bafna Pharma Standalone March 2020 Net Sales at Rs 13.13 crore, up 38.32% Y-o-Y
Bafna Pharma Standalone June 2019 Net Sales at Rs 6.85 crore, down 42.69% Y-o-Y
Bafna Pharma Standalone December 2018 Net Sales at Rs 13.07 crore, up 20.37% Y-o-Y
Stocks in news: Aurobindo, NALCO, Dabur, Manaksia, BEML, Sobha
Stocks in news: Tata Steel, BPCL, Bajaj Auto, Tata Elxsi
Stocks in news: ITC, Maruti, Eicher, MOIL, Mukand, Hathway Cable
Stocks in news: Torrent Power, GAIL, IOC, Eros, Aptech, Subros
Top buzzing midcap stocks to trade on June 10

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Bafna Pharmaceuticals

Bafna Pharma Standalone September 2025 Net Sales at Rs 35.47 crore, down 12.04% Y-o-Y

Bafna Pharma Standalone March 2025 Net Sales at Rs 39.06 crore, down 5.65% Y-o-Y

Bafna Pharma Standalone December 2024 Net Sales at Rs 33.19 crore, up 16.68% Y-o-Y

Bafna Pharma Standalone September 2024 Net Sales at Rs 40.32 crore, down 0.87% Y-o-Y

Bafna Pharma Standalone June 2024 Net Sales at Rs 33.29 crore, down 20.65% Y-o-Y

Bafna Pharma Standalone March 2024 Net Sales at Rs 41.40 crore, down 2% Y-o-Y

Bafna Pharma Standalone December 2023 Net Sales at Rs 28.44 crore, down 16.88% Y-o-Y

Bafna Pharma Standalone September 2023 Net Sales at Rs 40.68 crore, up 85.23% Y-o-Y

Bafna Pharma Standalone June 2023 Net Sales at Rs 41.95 crore, up 147.81% Y-o-Y

Bafna Pharma Standalone March 2023 Net Sales at Rs 42.24 crore, up 181.96% Y-o-Y

Bafna Pharma Standalone December 2022 Net Sales at Rs 34.22 crore, up 67.25% Y-o-Y

Bafna Pharma Standalone June 2022 Net Sales at Rs 16.93 crore, down 20.38% Y-o-Y

Bafna Pharma Standalone March 2022 Net Sales at Rs 14.98 crore, down 31.4% Y-o-Y

Bafna Pharma Standalone December 2021 Net Sales at Rs 20.46 crore, up 17.08% Y-o-Y

In talks with multinational pharma cos for acquisition of brands: Bafna Pharmaceuticals

Bafna Pharma Standalone June 2021 Net Sales at Rs 21.26 crore, up 27.28% Y-o-Y

Bafna Pharma Standalone December 2020 Net Sales at Rs 17.48 crore, up 59.95% Y-o-Y

Bafna Pharma Standalone March 2020 Net Sales at Rs 13.13 crore, up 38.32% Y-o-Y

Bafna Pharma Standalone June 2019 Net Sales at Rs 6.85 crore, down 42.69% Y-o-Y

Bafna Pharma Standalone December 2018 Net Sales at Rs 13.07 crore, up 20.37% Y-o-Y

Stocks in news: Aurobindo, NALCO, Dabur, Manaksia, BEML, Sobha

Stocks in news: Tata Steel, BPCL, Bajaj Auto, Tata Elxsi

Stocks in news: ITC, Maruti, Eicher, MOIL, Mukand, Hathway Cable

Stocks in news: Torrent Power, GAIL, IOC, Eros, Aptech, Subros

Top buzzing midcap stocks to trade on June 10